Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 5,121
Out of 5,124 analysts
16
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Beckley | Initiates: Buy | $18 | $4.09 | +340.10% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $26.71 | -36.35% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $6.90 | +392.75% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $182.64 | -47.99% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.33 | -14.16% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $330 | $7.57 | +4,259.31% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $0.85 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $5.18 | +517.76% | 4 | Dec 16, 2020 |
Atai Beckley
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $4.09
Upside: +340.10%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $26.71
Upside: -36.35%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $6.90
Upside: +392.75%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $182.64
Upside: -47.99%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.33
Upside: -14.16%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $330
Current: $7.57
Upside: +4,259.31%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.85
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $5.18
Upside: +517.76%